Cellebrite Di Ltd (CLBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 133,846 | 0 | N/A | N/A | N/A |
| Marketable Securities | 108,928 | 0 | N/A | N/A | N/A |
| Receivables | 66,324 | 0 | N/A | N/A | N/A |
| Inventories | 4,754 | 0 | N/A | N/A | N/A |
| Other current assets | 2,979 | 0 | 0 | 0 | 0 |
| TOTAL | $324,270 | $0 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 16,106 | 0 | N/A | N/A | N/A |
| Intangibles | 16,074 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 7,937 | 0 | 0 | 0 | 0 |
| TOTAL | $40,117 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $364,387 | $0 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 53,839 | 0 | 0 | 0 | 0 |
| TOTAL | $159,382 | $0 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 105,543 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 107,762 | 0 | 0 | 0 | 0 |
| TOTAL | $141,201 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $300,583 | $0 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 75,000 | N/A | N/A | N/A | N/A |
| Retained earnings | 28,342 | 0 | N/A | N/A | N/A |
| Other shareholders' equity | 1,236 | 0 | 0 | 0 | 0 |
| TOTAL | $63,804 | $0 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $364,387 | $0 | $0 | $0 | $0 |